United States · FDA National Drug Code directory
Cefoxitin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0143-9877_4638263b-1c03-4a32-ba82-70270cf42490
- Product NDC
- 0143-9877
- Form
- INJECTION, POWDER, FOR SOLUTION
- Composition / generic term
- Cefoxitin
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20100312
- Source listing expiry
- 20261231
Source-listed ingredients
- CEFOXITIN SODIUM — 2 g/1
These values do not establish equivalence or a dose recommendation.
Packages
- 25 VIAL in 1 CARTON (0143-9877-25) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0143-9877-01) · 0143-9877-25
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →